{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:45:13Z","timestamp":1784396713976,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03171-9","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:44:35Z","timestamp":1765266275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circular RNAs: emerging regulators of oxaliplatin response and resistance in cancer therapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Zahra","family":"Tajik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"8","key":"3171_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/1535-7163.MCT-14-0636","volume":"14","author":"E Martinez-Balibrea","year":"2015","unstructured":"Martinez-Balibrea E, Mart\u00ednez-Card\u00fas A, Gin\u00e9s A, de Ruiz Porras V, Moutinho C, Layos L, et al. Tumor-related molecular mechanisms of oxaliplatin resistance. Mol Cancer Ther. 2015;14(8):1767\u201376.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3171_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41419-025-07855-y","volume":"16","author":"SQR Wong","year":"2025","unstructured":"Wong SQR, Das M, Tenzin K, Shirgaonkar N, Chua H, Chee LX, et al. Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype. Cell Death Dis. 2025;16(1):529.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3171_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s11033-025-10908-2","volume":"52","author":"A Soleimani","year":"2025","unstructured":"Soleimani A, Ghafouri-Fard S. CircRNAs: emerging players in tyrosine kinase inhibitor resistance mechanisms in solid tumors. Mol Biol Rep. 2025;52(1):796.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3171_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s40001-025-03045-w","volume":"30","author":"Z Tajik","year":"2025","unstructured":"Tajik Z, Ghafouri-Fard S. Circular rnas: key regulators of Paclitaxel sensitivity and resistance in cancer. Eur J Med Res. 2025;30(1):758.","journal-title":"Eur J Med Res"},{"issue":"1","key":"3171_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01952-9","volume":"22","author":"M Sanati","year":"2024","unstructured":"Sanati M, Ghafouri-Fard S. The role of circRNAs in resistance to doxorubicin. Cell Commun Signal. 2024;22(1):572.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"3171_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/or.2021.8176","volume":"46","author":"C Xin","year":"2021","unstructured":"Xin C, Huang F, Wang J, Li J, Chen Q. Roles of circRNAs in cancer chemoresistance (Review). Oncol Rep. 2021. https:\/\/doi.org\/10.3892\/or.2021.8176.","journal-title":"Oncol Rep"},{"key":"3171_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109233","volume":"118","author":"X Hua","year":"2019","unstructured":"Hua X, Sun Y, Chen J, Wu Y, Sha J, Han S, et al. Circular RNAs in drug resistant tumors. Biomed Pharmacother. 2019;118:109233.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3171_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0092-8674(76)90223-3","volume":"8","author":"D Kolakofsky","year":"1976","unstructured":"Kolakofsky D. Isolation and characterization of Sendai virus DI-RNAs. Cell. 1976;8(4):547\u201355.","journal-title":"Cell"},{"issue":"11","key":"3171_CR9","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3171_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","volume":"12","author":"L Verduci","year":"2021","unstructured":"Verduci L, Tarcitano E, Strano S, Yarden Y, Blandino G. CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis. 2021;12(5):468.","journal-title":"Cell Death Dis"},{"issue":"38","key":"3171_CR11","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circrnas in cancer. Oncogene. 2023;42(38):2783\u2013800.","journal-title":"Oncogene"},{"issue":"8","key":"3171_CR12","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/thno.42174","volume":"10","author":"A Huang","year":"2020","unstructured":"Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503\u201317.","journal-title":"Theranostics"},{"issue":"6","key":"3171_CR13","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s12276-024-01220-3","volume":"56","author":"HJ Hwang","year":"2024","unstructured":"Hwang HJ, Kim YK. Molecular mechanisms of circular RNA translation. Exp Mol Med. 2024;56(6):1272\u201380.","journal-title":"Exp Mol Med"},{"key":"3171_CR14","doi-asserted-by":"publisher","first-page":"781414","DOI":"10.3389\/fonc.2021.781414","volume":"11","author":"M Taheri","year":"2021","unstructured":"Taheri M, Najafi S, Basiri A, Hussen BM, Baniahmad A, Jamali E, et al. The role and clinical potentials of circular RNAs in prostate cancer. Front Oncol. 2021;11:781414.","journal-title":"Front Oncol"},{"key":"3171_CR15","doi-asserted-by":"publisher","first-page":"153640","DOI":"10.1016\/j.prp.2021.153640","volume":"227","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Honarmand Tamizkar K, Jamali E, Taheri M, Ayatollahi SA. Contribution of circrnas in gastric cancer. Pathol Res Pract. 2021;227:153640.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"3171_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.20892\/j.issn.2095-3941.2020.0312","volume":"18","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang Y, Liu L, Yang T, Song J. Circular rnas: new biomarkers of chemoresistance in cancer. Cancer Biol Med. 2021;18(2):421\u201336.","journal-title":"Cancer Biol Med"},{"issue":"6","key":"3171_CR17","first-page":"647","volume":"38","author":"C Xiang","year":"2023","unstructured":"Xiang C, Li R, Qiu H, Zuo E, Zhang Y, Shan L, et al. Circular RNA circLRCH3 promotes oxaliplatin resistance in gastric cancer through the modulation of the miR-383-5p\/FGF7 axis. Histol Histopathol. 2023;38(6):647\u201358.","journal-title":"Histol Histopathol"},{"issue":"2","key":"3171_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10529-020-03036-3","volume":"43","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Wang D, Ding Y, Tian G, Jiang B. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p. Biotechnol Lett. 2021;43(2):339\u201351.","journal-title":"Biotechnol Lett"},{"issue":"1","key":"3171_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04235-y","volume":"21","author":"F Yang","year":"2023","unstructured":"Yang F, Ma Q, Huang B, Wang X, Pan X, Yu T, et al. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. J Transl Med. 2023;21(1):402.","journal-title":"J Transl Med"},{"key":"3171_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00363","volume":"7","author":"C Mancarella","year":"2019","unstructured":"Mancarella C, Scotlandi K. IGF2BP3 from physiology to cancer: novel discoveries, unsolved issues, and future perspectives. Front Cell Dev Biol. 2019;7:363.","journal-title":"Front Cell Dev Biol"},{"issue":"35","key":"3171_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204513","volume":"9","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zheng J, Zhang J, Lin J, Lai J, Lyu Z, et al. A novel protein encoded by exosomal CircATG4B induces oxaliplatin resistance in colorectal cancer by promoting autophagy. Adv Sci. 2022;9(35):e2204513.","journal-title":"Adv Sci"},{"key":"3171_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101097","volume":"76","author":"J Lin","year":"2024","unstructured":"Lin J, Lyu Z, Feng H, Xie H, Peng J, Zhang W, et al. CircPDIA3\/miR-449a\/XBP1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the GSDME-C domain to induce chemoresistance of colorectal cancer. Drug Resist Updat. 2024;76:101097.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"3171_CR23","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s11010-023-04819-8","volume":"479","author":"L Lv","year":"2024","unstructured":"Lv L, Yi L, Huang B, Zhou C, Zhang L. Hsa_circ_0071589 aggravates stemness and oxaliplatin resistance in colorectal cancer through sponging miR-133b to upregulate SOX13 expression. Mol Cell Biochem. 2024;479(8):2055\u201368.","journal-title":"Mol Cell Biochem"},{"key":"3171_CR24","doi-asserted-by":"publisher","first-page":"147323","DOI":"10.1016\/j.gene.2023.147323","volume":"864","author":"J Li","year":"2023","unstructured":"Li J, Lv J, Chen Y, Li L. Tumor suppressor circPDE4D inhibits the progression of colorectal cancer and regulates oxaliplatin chemoresistance. Gene. 2023;864:147323.","journal-title":"Gene"},{"issue":"3","key":"3171_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/cancers12030697","volume":"12","author":"YC Lin","year":"2020","unstructured":"Lin YC, Yu YS, Lin HH, Hsiao KY. Oxaliplatin-induced DHX9 phosphorylation promotes oncogenic circular RNA CCDC66 expression and development of chemoresistance. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12030697.","journal-title":"Cancers (Basel)"},{"key":"3171_CR26","doi-asserted-by":"publisher","first-page":"11257","DOI":"10.2147\/CMAR.S270123","volume":"12","author":"S Li","year":"2020","unstructured":"Li S, Zheng S. Down-regulation of Circ_0032833 sensitizes colorectal cancer to 5-Fluorouracil and oxaliplatin partly depending on the regulation of miR-125-5p and MSI1. Cancer Manag Res. 2020;12:11257\u201369.","journal-title":"Cancer Manag Res"},{"issue":"8","key":"3171_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2217\/epi-2019-0042","volume":"11","author":"N Abu","year":"2019","unstructured":"Abu N, Hon KW, Jeyaraman S, Yahaya A, Abdullah NM, Mustangin M, et al. Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer. Epigenomics. 2019;11(8):875\u201384.","journal-title":"Epigenomics"},{"issue":"9","key":"3171_CR28","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1111\/jcmm.15122","volume":"24","author":"M Lai","year":"2020","unstructured":"Lai M, Liu G, Li R, Bai H, Zhao J, Xiao P, et al. Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-\u03b1 pathway in human colon cancer. J Cell Mol Med. 2020;24(9):5021\u20137.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3171_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/1120009X.2023.2253680","volume":"36","author":"J Chen","year":"2024","unstructured":"Chen J, Wang H, Tang M. CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner. J Chemother. 2024;36(3):208\u201321.","journal-title":"J Chemother"},{"issue":"1","key":"3171_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1515\/biol-2022-0036","volume":"17","author":"W Liu","year":"2022","unstructured":"Liu W, Jiang H, Li Y. Silencing circular RNA-friend leukemia virus integration 1 restrained malignancy of CC cells and oxaliplatin resistance by disturbing dyskeratosis congenita 1. Open Life Sci. 2022;17(1):563\u201376.","journal-title":"Open Life Sci"},{"issue":"2","key":"3171_CR31","first-page":"209","volume":"38","author":"S Zhao","year":"2023","unstructured":"Zhao S, Xu F, Ji Y, Wang Y, Wei M, Zhang L. Circular RNA circ-CD44 regulates chemotherapy resistance by targeting the miR-330-5p\/ABCC1 axis in colorectal cancer cells. Histol Histopathol. 2023;38(2):209\u201321.","journal-title":"Histol Histopathol"},{"key":"3171_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155476","volume":"260","author":"L Xiao","year":"2024","unstructured":"Xiao L, Zhu Y, Xu H, Lin L, Li M, Zhou Y. Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p\/MYO6 in colorectal cancer. Pathol Res Pract. 2024;260:155476.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"3171_CR33","first-page":"1145","volume":"38","author":"X Qiu","year":"2023","unstructured":"Qiu X, Xu Q, Liao B, Hu S, Zhou Y, Zhang H. Circ-CCS regulates oxaliplatin resistance via targeting miR-874-3p\/HK2 axis in colorectal cancer. Histol Histopathol. 2023;38(10):1145\u201356.","journal-title":"Histol Histopathol"},{"key":"3171_CR34","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2147\/OTT.S281238","volume":"14","author":"H Gao","year":"2021","unstructured":"Gao H, Xu J, Qiao F, Xue L. Depletion of hsa_circ_0000144 suppresses oxaliplatin resistance of gastric cancer cells by regulating miR-502-5p\/ADAM9 axis. Onco Targets Ther. 2021;14:2773\u201387.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3171_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s42003-024-06213-6","volume":"7","author":"QY Chen","year":"2024","unstructured":"Chen QY, Xu KX, Huang XB, Fan DH, Chen YJ, Li YF, et al. Circ-0075305 hinders gastric cancer stem cells by indirectly disrupting TCF4-\u03b2-catenin complex and downregulation of SOX9. Commun Biol. 2024;7(1):545.","journal-title":"Commun Biol"},{"issue":"6","key":"3171_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23918","volume":"36","author":"C Chang","year":"2022","unstructured":"Chang C, Zheng A, Wang P, Teng X. Circular RNA mitochondrial translation optimization 1 correlates with less lymph node metastasis, longer disease-free survival, and higher chemotherapy sensitivity in gastric cancer. J Clin Lab Anal. 2022;36(6):e23918.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"3171_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbrc.2019.10.117","volume":"521","author":"Q Wu","year":"2020","unstructured":"Wu Q, Wang H, Liu L, Zhu K, Yu W, Guo J. Hsa_circ_0001546 acts as a miRNA-421 sponge to inhibit the chemoresistance of gastric cancer cells via ATM\/Chk2\/p53-dependent pathway. Biochem Biophys Res Commun. 2020;521(2):303\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3171_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155596","volume":"263","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Q, Xu Q, Liao B, Qiu X. Circ_0006089 facilitates gastric cancer progression and oxaliplatin resistance via miR-217\/NRP1. Pathol Res Pract. 2024;263:155596.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"3171_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","volume":"42","author":"S Zheng","year":"2023","unstructured":"Zheng S, Tian Q, Yuan Y, Sun S, Li T, Xia R, et al. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via sumoylation modulation in pancreatic cancer. J Exp Clin Cancer Res. 2023;42(1):324.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3171_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41419-025-07431-4","volume":"16","author":"R He","year":"2025","unstructured":"He R, Hu C, Yuan Y, Li T, Tian Q, Huang T, et al. Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation. Cell Death Dis. 2025;16(1):126.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3171_CR41","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.21037\/jgo-21-567","volume":"12","author":"L Bao","year":"2021","unstructured":"Bao L, Wang M, Fan Q. Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma. J Gastrointest Oncol. 2021;12(5):2388\u2013402.","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"3171_CR42","first-page":"1239","volume":"40","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang L, Yin G, Li H, Zhang R, Feng Y, et al. Hsa_circ_0088036 promotes tumorigenesis and chemotherapy resistance in hepatocellular carcinoma via the miR-140-3p\/KIF2A axis. Histol Histopathol. 2025;40(8):1239\u201351.","journal-title":"Histol Histopathol"},{"issue":"1","key":"3171_CR43","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1080\/21655979.2021.1951929","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao Y, Li X, Cheng L, Wu X, Wu B. Circular RNA FAT atypical Cadherin 1 (circFAT1)\/microRNA-525-5p\/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the Notch and Wnt signaling pathway. Bioengineered. 2021;12(1):4032\u201343.","journal-title":"Bioengineered"},{"issue":"3","key":"3171_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1878-0261.12629","volume":"14","author":"X Wang","year":"2020","unstructured":"Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14(3):539\u201355.","journal-title":"Mol Oncol"},{"issue":"1","key":"3171_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4149\/neo_2020_200417N414","volume":"68","author":"Y Xu","year":"2021","unstructured":"Xu Y, Qiu A, Peng F, Tan X, Wang J, Gong X. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p. Neoplasma. 2021;68(1):108\u201318.","journal-title":"Neoplasma"},{"issue":"1","key":"3171_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13577-022-00790-6","volume":"36","author":"Y Chen","year":"2023","unstructured":"Chen Y, Liu H, Zou J, Cao G, Li Y, Xing C, et al. Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p\/TRIM14\/Dvl2\/Wnt\/\u03b2-catenin axis. Hum Cell. 2023;36(1):258\u201375.","journal-title":"Hum Cell"},{"issue":"1","key":"3171_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12951-024-02331-9","volume":"22","author":"B Hui","year":"2024","unstructured":"Hui B, Zhou C, Xu Y, Wang R, Dong Y, Zhou Y, et al. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085. J Nanobiotechnol. 2024;22(1):62.","journal-title":"J Nanobiotechnol"},{"key":"3171_CR48","doi-asserted-by":"publisher","first-page":"2878557","DOI":"10.1155\/2022\/2878557","volume":"2022","author":"C Li","year":"2022","unstructured":"Li C, Li X. Exosome-Derived Circ_0094343 promotes chemosensitivity of colorectal cancer cells by regulating Glycolysis via the miR-766-5p\/TRIM67 axis. Contrast Media Mol Imaging. 2022;2022:2878557.","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"3171_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40291-021-00573-z","volume":"26","author":"H Yasuhara","year":"2022","unstructured":"Yasuhara H, Yoshida T, Sasaki K, Obika S, Inoue T. Reduction of off-target effects of Gapmer antisense oligonucleotides by oligonucleotide extension. Mol Diagn Ther. 2022;26(1):117\u201327.","journal-title":"Mol Diagn Ther"},{"key":"3171_CR50","doi-asserted-by":"publisher","first-page":"1143157","DOI":"10.3389\/fbioe.2023.1143157","volume":"11","author":"C Guo","year":"2023","unstructured":"Guo C, Ma X, Gao F, Guo Y. Off-target effects in CRISPR\/Cas9 gene editing. Front Bioeng Biotechnol. 2023;11:1143157.","journal-title":"Front Bioeng Biotechnol"},{"key":"3171_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215557","author":"A Vall\u00e9e","year":"2021","unstructured":"Vall\u00e9e A, Lecarpentier Y, Vall\u00e9e JN. The key role of the WNT\/\u03b2-catenin pathway in metabolic reprogramming in cancers under normoxic conditions. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13215557.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3171_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2025.100198","volume":"48","author":"KY Koo","year":"2025","unstructured":"Koo KY, Moon K, Song HS, Lee M-S. Metabolic regulation by p53: implications for cancer therapy. Molecules Cells. 2025;48(4):100198.","journal-title":"Molecules Cells"},{"issue":"9","key":"3171_CR53","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/aps.2010.151","volume":"31","author":"XD Zhang","year":"2010","unstructured":"Zhang XD, Qin ZH, Wang J. The role of p53 in cell metabolism. Acta Pharmacol Sin. 2010;31(9):1208\u201312.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03171-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:03:04Z","timestamp":1769490184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03171-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03171-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"38"}}